Skip to main content

Animations

MJFF Publications

5641 - 5650 of 6514 Results
Title
Year
  • Year
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • Summary Details
    OPEN
    Title: Seed Amplification Assay to Diagnose Early Parkinson's and Predict Dopaminergic Deficit Progression
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd, cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.28715
    Citation Count: 64
  • Summary Details
    OPEN
    Title: Sex differences for phenotype in pathologically defined dementia with Lewy bodies
    Journal Name: Journal of Neurology, Neurosurgery & Psychiatry
    Publisher: BMJ
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1136/jnnp-2020-325668
    Citation Count: 50
  • Summary Details
    OPEN
    Title: Subthalamic Peak Beta Ratio Is Asymmetric in Glucocerebrosidase Mutation Carriers With Parkinson's Disease: A Pilot Study
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2021.723476
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Predicting PY motif-mediated protein-protein interactions in the Nedd4 family of ubiquitin ligases
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0258315
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Relationships between Mitochondrial Function, AMPK, and TORC1 Signaling in Lymphoblasts with Premutation Alleles of the FMR1 Gene
    Journal Name: International Journal of Molecular Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/ijms221910393
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Perception and Use of Compensation Strategies for Gait Impairment by Persons With Parkinson Disease
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000012633
    Citation Count: 28
  • Summary Details
    OPEN
    Title: A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2021.705407
    Citation Count: 81
  • Summary Details
    OPEN
    Title: A six-metabolite panel as potential blood-based biomarkers for Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-021-00239-x
    Citation Count: 52
  • Summary Details
    OPEN
    Title: Walking on common ground: a cross-disciplinary scoping review on the clinical utility of digital mobility outcomes
    Journal Name: npj Digital Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41746-021-00513-5
    Citation Count: 103
  • Summary Details
    OPEN
    Title: Salivary Lactoferrin Expression in a Mouse Model of Alzheimer’s Disease
    Journal Name: Frontiers in Immunology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fimmu.2021.749468
    Citation Count: 21
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.